EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.
about
The impact of epidermal growth factor receptor mutations on patterns of disease recurrence after chemoradiotherapy for locally advanced non-small cell lung cancer: a literature review and pooled analysisEvaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer.Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901.Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504)Treating advanced non-small cell lung cancer in the elderly.Causal effects of time-dependent treatments in older patients with non-small cell lung cancer.A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (tSecond-line treatment of stage III/IV non-small-cell lung cancer (NSCLC) with pemetrexed in routine clinical practice: evaluation of performance status and health-related quality of life.Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer.Therapeutic options in older patients with metastatic non-small cell lung cancer.Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesEarly and long-term results of pulmonary resection for non-small-cell lung cancer in patients over 75 years of age: a multi-institutional study.Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients.Age is a prognostic factor affecting survival in lung cancer patients.Treatment outcomes in elderly with advanced-stage non-small cell lung cancerDo we protect or discriminate? Representation of senior adults in clinical trials.Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India.The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapyCurative resection for lung cancer in octogenarians is justified.Optimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancer.Treatment of elderly patients with stage IV non-small-cell lung cancer.A review of the management of elderly patients with non-small-cell lung cancer.Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients.Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer.Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians.Recent advances in targeted advanced lung cancer therapy in the elderly.Lobar and sub-lobar lung resection in octogenarians with early stage non-small cell lung cancer: factors affecting surgical outcomes and long-term results.Carboplatin-containing regimens as front-line treatment for advanced non-small-cell lung cancer in two groups of elderly.Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.General recommendations paper on the management of older patients with cancer: the SEOM geriatric oncology task force's position statement.Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer.Does age over 80 years have to be a contraindication for lung cancer surgery-a nationwide database study
P2860
Q26741041-379633AB-6931-4655-BD92-F77A849910F1Q33398466-45BD0FD2-D6FE-4052-BE41-8751225B7A95Q33406653-61A8382B-2310-4283-B2F4-934A3F6A8321Q34346373-374F20D2-DADC-44EB-AA3D-7AA72E3A0EECQ35076283-D32472A5-F2FC-4E97-AD84-F20F078DE378Q35302530-6966F73E-BC0C-494C-A078-757AB622386DQ35527102-45F3B5B6-25A0-412C-BDA3-FB88EAA5009AQ35802325-82C6857A-9841-4244-90A6-AF64DDAEED2EQ36055304-9D168770-E4DA-4EFE-AF0D-D7EEC9634ADFQ36180083-3B14F8D4-2941-45A0-9281-927EF8053BE5Q36412597-86516855-8FBC-494B-92C2-24B3AF97832DQ36599687-50BCC1D7-F6A4-4C02-806C-7F0C208105D5Q36789292-3F7CB09A-CC19-4C25-928F-4D379BC9A08AQ37269229-6C38037D-9EF7-4AAD-AC7A-016396B8F473Q37333926-2C344C12-BC87-4145-8793-A946B5E299DFQ37392261-DC1E1428-5F8D-44A1-A1A2-88265FA306E2Q37467273-248CB56F-CF92-4F27-8DFB-FE50FC78EE6AQ37566016-2E9C42F4-8632-47CA-A842-DA6E59EBADCBQ37677572-140306EB-397E-4E0E-A5F3-7236750352E9Q37952852-CFCAD67F-D515-4721-962E-C6F316E99D78Q37965641-DE0DE682-0EBB-4BFC-98FF-62D83E135F61Q38233740-6B2D7B92-A3E9-4C88-BBAE-092F86FC7B0EQ38560967-F887A9E0-3B81-472D-B07E-DD01DE5F5213Q38594474-33F514EE-9F9B-47D3-95A6-BD1C9DC290F0Q39251171-E393E924-C2D9-4BD7-92AA-1718F9083954Q40143039-EA1ADA4A-A083-4288-B263-0B72DF277C35Q44276546-356176B9-03F3-4E8A-9819-892E763A7DAAQ46292587-843ABEE2-810D-44B1-9E61-D6B6D5912655Q53061916-AA8CBFEE-B979-4389-9128-660057936B02Q53823553-135D004C-B0E1-45DC-BDA9-C6122753B286Q54308862-EA8B55B2-7038-410F-A2BA-EF21F8D621FEQ58804484-AC52BCC0-4FF4-461B-ACBA-30CBE48F4B3A
P2860
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EORTC Elderly Task Force and L ...... ncer in an elderly population.
@en
EORTC Elderly Task Force and L ...... Society for Geriatric Oncology
@nl
type
label
EORTC Elderly Task Force and L ...... ncer in an elderly population.
@en
EORTC Elderly Task Force and L ...... Society for Geriatric Oncology
@nl
prefLabel
EORTC Elderly Task Force and L ...... ncer in an elderly population.
@en
EORTC Elderly Task Force and L ...... Society for Geriatric Oncology
@nl
P2093
P2860
P356
P1433
P1476
EORTC Elderly Task Force and L ...... ancer in an elderly population
@en
P2093
A G Pallis
C Gridelli
J P van Meerbeeck
L Greillier
P2860
P304
P356
10.1093/ANNONC/MDP360
P577
2009-08-28T00:00:00Z